Home / Research Library / LIBIDO · Melanocortin and Receptor Research
LIBIDO · Melanocortin and Receptor Research

Melanotan II: A Research Overview

2026-06-08 · ~4 min read · For laboratory and educational use only

All information here is for laboratory and educational research only. No compound referenced is approved for human or veterinary use, and nothing here is medical advice.

The short version
  • Melanotan II is a lab-made copy of a natural hormone that switches on the body's pigment system. Scientists use it as a tool to study how those pigment signals work.
  • The research is thin and early. A small early-stage human study measured more skin pigment after it was given, but the human evidence is limited and the full list of side effects is not well understood.
  • There is a real safety warning in the literature: one published case linked Melanotan II use, combined with sunbed exposure, to skin cancer (melanoma).
  • It is not approved by the FDA or any regulator for people or animals, and it has been the subject of consumer-safety warnings. Online tanning-forum reports about it are unverified personal stories, not proven findings.
  • BioRegen sells Melanotan II strictly for laboratory and educational research only, makes no claim that it works, and offers no human use or dosing guidance.

All information here is for laboratory and educational research only. No compound referenced is approved for human or veterinary use, and nothing here is medical advice. Melanotan II (often shortened to MT-II) is a lab-made peptide. A peptide is a small chain of the building blocks that make up proteins. It is built to look like a natural body signal called alpha-MSH (short for alpha-melanocyte-stimulating hormone). Scientists use MT-II as a tool to study a body signaling system called the melanocortin system. This article pulls together what published studies say about the compound and where the research stands today.

What Melanotan II Is

Melanotan II is a ring-shaped peptide. Its design copies the active part of the natural alpha-MSH signal. Published research describes it as a strong, broad-acting "agonist." An agonist is something that switches a receptor on. A receptor is a docking spot on a cell that picks up a signal. MT-II is broad-acting because it switches on several of these docking spots in the melanocortin family at once, not just one. Its ring shape also makes it break down more slowly than the natural signal, which is one reason scientists have used it as a study tool. It is sold only as a research chemical for lab work in test tubes and cell studies.

How It Works and What Research Looks At

The melanocortin system is made up of five receptors, named MC1R through MC5R. These docking spots help control things like skin color, the body's energy use, and inflammation. Researchers study MT-II partly because it switches on several of these receptors at once, so they can look at many parts of the system in one experiment. Studies have looked at how MT-II works with MC1R, the receptor most tied to making the pigment that colors skin. They have also looked at receptors in the brain that are studied in connection with appetite and other signals. Because the compound turns on more than one receptor, much of the research tries to figure out which receptor is behind which effect.

Skin Color Research

Skin color is the area where MT-II has been studied the most. An early, small, carefully run study, called a pilot phase-I study, reported a measurable rise in skin color in the people who took part. Researchers measured this with a light-reading device and by looking at the skin. Scientists study this color-making activity as a way to understand how the MC1R receptor drives the pigment that colors skin. Just as important, the published research also flags safety concerns. One case report linked MT-II to melanoma, a serious skin cancer, in a person who used this unapproved compound along with tanning beds. That shows the effects on skin color come with real, unanswered safety questions. BioRegen does not make or support any medical claims about this compound.

Where the Research Stands, Its Limits, and Handling

Melanotan II is still an unapproved research compound that has not been fully tested. The published human studies are few, small, and early, and the full list of possible harms is not well understood. This is an early, experimental stage of research, not settled proof, and no health authority has approved MT-II for use in people or animals. You may also see informal stories about it in online groups. These are just personal stories, not careful study results, and BioRegen does not make or support any claims based on them. MT-II comes as a freeze-dried powder. In a lab it is usually kept cold and away from light, the way labs handle peptides in general. Researchers mix it back into liquid in the lab using a special sterile water before study. For lab mixing practice, see our guide on how to reconstitute peptides.

Is Melanotan II approved for use?

No. It is an unapproved research chemical. No compound mentioned here is approved for use in people or animals, and it is sold only for lab and educational research.

Which receptors does Melanotan II act on?

Published research describes it as a broad-acting switch for melanocortin receptors. It turns on several of them, including MC1R, the receptor studied for its role in making the pigment that colors skin.

Why do researchers study it?

Because it switches on several melanocortin receptors at once, it is a handy study tool for looking at many parts of this signaling system at the same time, especially the parts tied to skin color.


Exploring the melanocortin pathway for your laboratory work? Start with our research guide, and create a free account for 10% off your first order. You can compare compounds with our research finder or browse related materials in the libido research category.

Selected research references

Reference metadata sourced via PubMed.

This article is provided for laboratory and educational research purposes only. No compound referenced is approved for human or veterinary use, nothing here constitutes medical advice, and no claim is made that any compound treats, cures, or prevents any condition.

The evidence spectrum

The full research picture, clearly labeled

BioRegen reports the entire research landscape for this compound across four clearly separated tiers, strongest evidence first. Lower tiers, including community and anecdotal reports, are labeled as such and are not BioRegen claims.

Clinical Human trials

Human data is limited. Afamelanotide, related to Melanotan I, has regulatory approval in a narrow dermatologic indication; Melanotan II has no such approval and limited controlled human data, alongside documented safety concerns.

Preclinical Lab and animal

Melanocortin-receptor research has studied pigmentation pathways and related signaling in models.

Anecdotal Community, unverified

Melanotan II is widely discussed in tanning and community forums, where reports of side effects are also common. These are unverified anecdotal reports, not controlled findings, and not BioRegen claims.

Regulatory Approval status

Melanotan II is not FDA-approved and has been the subject of consumer-safety warnings. BioRegen supplies these melanocortin reference materials strictly for laboratory and educational research, not for human use.

Tiers are evidence categories, not endorsements. Clinical and preclinical entries summarize third-party published research. Community and anecdotal entries are unverified reports discussed by others, not findings and not BioRegen claims. Nothing here is medical advice, and no compound is approved for human or veterinary use except where explicitly stated under Regulatory status.

In the catalog

Shop these research materials

Related research

More peptide research to explore

Explore the research line

Browse the BioRegen catalog, or grab the free reference guide · create a free account for 10% off your first order.